Effect of melatonin and melatonylvalpromide on β-amyloid and neurofilaments in N2a cells

Neurochemical Research

Volumn 33, Issue 6, 2008, Pages 1138-1144

  Wang, Xiao Chuan ^a   Zhang, Yin Chun ^a   Chatterjie, Nithiananda ^b   Grundke Iqbal, Inge ^b   Iqbal, Khalid ^b   Wang, Jian Zhi ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Amyloid; Alzheimer's disease; Melatonin; Melatonylvalproylamide; Neurofilament

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; EPITOPE; MELATONIN; MELATONIN DERIVATIVE; MELATONYLVALPROMIDE; NEUROFILAMENT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL LYSATE; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MOUSE; NEUROFILAMENT; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; WILD TYPE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; CELL LINE, TUMOR; MELATONIN; MICE; NEUROBLASTOMA; NEUROFILAMENT PROTEINS; VALPROIC ACID;

MURINAE;

EID: 42149135452     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-007-9563-y     Document Type: Article

References (37)

1. Armstrong RA (2006) Plaques and tangles and the pathogenesis of Alzheimer's disease. Folia Neuropathol 44:1-11
2. Selkoe DJ (2002) Alzheimer's disease is a synaptic failure. Science 298:789-791
3. Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y (1994) Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ42(43). Neuron 13:45-53
4. Roher A, Wolfe D, Palutke M, KuKuruga D (1998) Purification, ultrastructure, and chemical analysis of Alzheimer disease amyloid plaque core protein. Proc Natl Acad Sci USA 83:2662-2666
5. Cai XD, Golde TE, Younkin SG (1993) Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. Science 259:514-516
6. Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Selkoe DJ (1992) Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases betaprotein production. Nature 360:672-674
7. Citron M, Teplow DB, Selkoe DJ (1995) Generation of amyloid beta protein from its precursor is sequence specific. Neuron 14:661-670
8. Hardy J (1999) The shorter amyloid cascade hypothesis. Neurobiol Aging 20:85
9. Grundke-Iqbal I, Iqbal K, Quinlan M, Tung YC, Zaidi MS, Wisniewski HM (1986) Microtubule-associated protein tau, a component of paired helical filaments. J Biol Chem 261:6084-6089
10. Drubin DG, Kirschner MW (1986) Tau protein function in living cells. J Cell Biol 103:2739-2746
11. Willard M, Simon C (1981) Antibody decoration of neurofilament. Cell Biol 89:198-205
12. Wang JZ, Tung YC, Wang YP, Li XT, Iqbal K, Grundke-Iqbal I (2001) Hyperphosphorylation and accumulation of neurofilament proteins in Alzheimer disease brain and in okadaic acid-treated SY5Y cells. FEBS Lett 507:81-87
13. Hu YY, He SS, Wang XC, Grundke-Iqbal I, Iqbal K, Wang JZ (2002) Elevated level of phosphorylated neurofilament in CSF of AD. Neurosci Lett 320:156-160
14. Kittur S, Hoh J, Endo H, Tourtellotte W, Weeks BS, Markesbery W (1994) Cytoskeletal neurofilament gene expression in brain tissue from Adpatients. I. Decrease in NF-L and NF-M message. J Geriatr Psychiatry Neurol 7:153-158
15. Magri F, Sarra S, Cinchetti W, Guazzoni V, Fioravanti M, Cravello L (2004) Qualitative and quantitative changes of melatonin levels in physiological and pathological aging and in centenarians. J Pineal Res 36:256-261
16. Lahiri DK, Ge YW, Sharman EH, Bondy SC (2004) Age-related changes in serum melatonin in mice: higher levels of combined melatonin and 6-hydroxymelatonin sulfate in the cerebral cortex than serum, heart, liver and kidney tissues. J Pineal Res 36:217-223
17. Liu RY, Zhou JN, van Heerikhuize J, Hofman MA, Swaab DF (1999) Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer's disease, and apolipoprotein E-epsilon4/4 genotype. J Clin Endocrinol Metab 84:323-327
18. Wu YH, Feenstra MG, Zhou JN, Liu RY, Torano JS, Van Kan HJ (2003) Molecular changes underlying reduced pineal melatonin levels in Alzheimer disease: alterations in preclinical and clinical stages. J Clin Endocrinol Metab 88:5898-5906
19. Pappolla M, Bozner P, Soto C, Shao HY, Robakis NK, Zagorski M (1998) Inhibition of Alzheimer β-fibrillogengsis by melatonin. J Biol Chem 273:7185-7188
20. Pappolla MA, Chyan YJ, Poeggeler B, Frangione B, Wilson G, Ghiso J (2000) An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease. J Neural Transm 107:203-231
21. Castro LM, Gallant M, Niles LP (2005) Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells. J Neurochem 95:1227-1236
22. Chatterjie N, Alexander G, Wang H (2001) Synthesis of valproic acid amides of a melatonin derivative, a piracetam and amantadine for biological tests. Neurochem Res 26:1171-1176
23. Yamamoto T, Yuyama K, Nakamura K, Kato T, Yamamoto H (2000) Kinetic characterization of the nitric oxide toxicity for pc12 cells: effect of half-life time of no release. Eur J Pharmacol 397:25-33
24. Turner RS, Suzuki N, Chyung AS, Younkin SG, Lee VM (1996) Amyloids β40 and β42 are generated intracellularly in cultured human neurons and their secretion increases with maturation. J Biol Chem 271:8966-8970
25. Zhang YC, Wang ZF, Wang Q, Wang YP, Wang JZ (2004) Melatonin attenuates overproduction of β-amyloid-induced inhibition in expression of neurofilament protein. Acta Pharmacol Sin 25:447-451
26. Sternberger NH, Sternberger LA, Ulrich J (1985) Aberrant neurofilament phosphorylation in Alzheimer disease. PNAS 82:4274-4276
27. Wang DL, Ling ZQ, Cao FY, Zhu LQ, Wang JZ (2004) Melatonin attenuates isoproterenol-induced protein kinase A overactivation and tau hyperphosphorylation in rat brain. J Pineal Res 37:11-16
28. Selkoe DJ (1996) Amyloid β-protein and the genetics of Alzheimer's disease. J Biol Chem 271:18295-18298
29. Gouras GK, Almeida CG, Takahashi RH (2005) Intraneuronal Aβ accumulation and origin of plaques in Alzheimer's disease. Neurobiol Aging 26:1235-1244
30. Tickler AK, Wade JD, Separovic F (2005) The role of Aβ peptides in Alzheimer's disease. Protein Pept Lett 12:513-519
31. Yang Y, Dowling J, Yu QC, Kouklis P, Cleveland DW, Fuchs E (1996) An essential cytoskeleton linker protein connecting actin microfilaments to intermediate filaments. Cell 86:655-665
32. Ferrari E, Arcaini A, Gornati R, Pelanconi L, Cravello L, Fioravanti M (2000) Pineal and pituitary-adrenocortical function in physiological aging and in senile dementia. Exp Gerontol 35:1239-1250
33. Maurizi CP (2001) Alzheimer's disease: roles for mitochondrial damage, the hydroxyl radical, and cerebrospinal fluid deficiency of melatonin. Med Hypotheses 57:156-160
34. Li SP, Deng YQ, Wang XC, Wang YP, Wang JZ (2004) Melatonin protects SH-SY5Y neuroblastoma cells from calyculin A-induced neurofilament impairment and neurotoxicity. J Pineal Res 36:186-191
35. Li XC, Wang ZF, Zhang JX, Wang Q, Wang JZ (2005) Effect of melatonin on calyculin A-induced tau hyperphosphorylation. Eur J Pharmacol 510:25-30
36. Deng YQ, Xu GG, Duan P, Zhang Q, Wang JZ (2005) Effects of melatonin on wortmannin-induced tau hyperphosphorylation. Acta Pharmacol Sin 26:519-526
37. Wang JZ, Wang ZF (2006) Role of melatonin in Alzheimer-like neurodegeneration. Acta Pharmacol Sin 27:41-49